
The weight loss pill arrives
An oral version of semaglutide, the same active ingredient as Wegovy, was approved by the US regulator on 22 December 2025 and went on sale there in early January 2026. In its OASIS-4 trial it produced average weight loss of around 16.6% with full adherence (13.6% across all participants). The MHRA approved the oral obesity dose in the UK on 11 June 2026, the first weight-loss tablet licensed here. It is now available to pre-order through Easy Pharmacy, with every request reviewed by a pharmacist before supply. See our Wegovy Pill page for details.









